The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats

Pharmacological Research

Volumn 47, Issue 6, 2003, Pages 517-522

  Mora, Luciana de Oliveira ^a,b   Antunes, Lusânia Maria Greggi ^c   Francescato, Heloísa Della Coletta ^a   Bianchi, Maria de Lourdes Pires ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cisplatin; Glutamine; Lipid peroxidation; Nephrotoxicity

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; CISPLATIN; CREATININE; GLUTAMINE; GLUTATHIONE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; GLUTATHIONE METABOLISM; KIDNEY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SINGLE DRUG DOSE; URINE VOLUME; WEIGHT REDUCTION;

EID: 0037624830     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00040-9     Document Type: Article

References (33)

1. Bergström J., Fürst P., Norée L.O., Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J. Appl. Physiol. 36:1974;693-696.
2. Hall J.C., Heel K., McCauly R. Glutamine. Br. J. Surg. 83:1996;305-312.
3. Welbourne T.C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can. J. Biochem. 57:1979;233-237.
4. Mora L.O., Antunes L.M.G., Bianchi M.L.P. The effects of glutamine on cisplatin-induced genotoxicity in Wistar rat bone marrow cells. Mutat. Res. 518:2002;65-70.
5. Blachley J.D., Hill J.B. Renal and electrolyte disturbances associated with cisplatin. Ann. Int. Med. 95:1981;628-632.
6. Weijl N.I., Cleton F.J., Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev. 23:1997;209-240.
7. Baldew G., van den Hamer C.J., Los G., Vermeulen N.P., Goeij J.J., McVie J.G. Selenium induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats. Cancer Res. 49:1989;3020-3023.
8. Francescato H.D.C., Costa R.S., Camargo S.M.R., Zanetti M.A., Lavrador M.A., Bianchi M.L.P. Effect of dietary oral selenium on cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 43:2001;77-82.
9. Appenroth D., Fröb S., Kersten L., Splinter F.-K., Winnefeld K. Protective effects of Vitamins E and C on cisplatin nephrotoxicity in developing rats. Arch. Toxicol. 71:1997;677-683.
10. Antunes L.M.G., Darin J.D.C., Bianchi M.L.P. Protective effects of Vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adults rats, a dose-dependent study. Pharmacol. Res. 41:2000;405-411.
11. Antunes L.M.G., Araújo M.C.P., Darin J.D.C., Bianchi M.L.P. Effects of the antioxidants curcumin and Vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat. Res. 465:2000;131-137.
12. Silva C.R., Antunes L.M.G., Bianchi M.L.P. Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. Pharmacol. Res. 43(6):2001;561-566.
13. Kroning R., Lichestenstein A.K., Nagami G.T. Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubular epithelial cell lines. Cancer Chemother Pharmacol. 45:2000;43-49.
14. Sedlak M., Lindsay R. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:1968;192-205.
15. Hartree E. Determination of protein: a modification of long method that gives a linear photometric response. Anal. Biochem. 48:1972;422-427.
16. Uchiyama M., Mihara M. Determination of malonaldeyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86:1978;271-278.
17. Matsushima H., Yonemura K., Ohishi K., Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J. Lab. Clin. Med. 131:1998;518-526.
18. Daugaard G., Abilgaard U., Holstein-Rathlou N.H., Bruunshuus I., Bucher D., Leyssac P.P. Renal tubular function in patients treated with high-dose cisplatin. Clin. Pharmacol. Ther. 44:1988;164-172.
19. Donadio C., Lucchesi A., Tramonti G., Bianchi C. Creatinine clearance predicted from body cells mass is a good indicator of renal function. Kidney Int. 52(Suppl 63):1997;S166-S168.
20. Jeong J.C., Hwang W.M., Yoon C.H., Kim Y.K. Salviae radix extract prevents cisplatin-induced acute renal failure. Nephron. 88:2001;241-246.
21. Antunes L.M.G., Darin J.D.C., Bianchi M.L.P. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol. Res. 43:2001;145-150.
22. Hamilton T.C., Winker M.A., Louie K.G., Batist G., Behrens B.C., Tsuruo T. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian cancer cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol. 34:1985;2583-2586.
23. Husain K., Morris C., Whitworth C., Trammel G.L., Rybak L.P., Somant S.M. 4-Methylthiobenzoic acid protection against cisplatin nephrotoxicity: antioxidants system. Fundam. Appl. Toxicol. 32:1996;278-284.
24. Tian L., Shi M.M., Forman H.J. Increased transcription of the regulatory subunit of γ-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion. Arch. Biochem. Biophys. 342:1997;126-133.
25. Neu J., Shenoy V., Chakrabarti R. Glutamine nutrition and metabolism: where do we go from here? FASEB J. 10:1996;829-837.
26. Sugihara K., Nakano S., Koda M., Tanaka K., Fukuishi N., Gemba M. Stimulatory effect of cisplatin on lipid peroxidation in renal tissues. Jpn. J. Pharmacol. 43:1987;247-252.
27. Kruidering M., van de Water B., de Heer E., Mulder G.J., Nagelkerke J.F. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 280:1997;638-649.
28. Bokemeyer C., Fels L.M., Dunn T., Voigt W., Gaedeke J., Schmoll H.J.et al. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. Br. J. Cancer. 74:1996;2036-2041.
29. Rao M., Kumar M.M., Rao M.A. In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. J. Biochem. 125:1999;383-390.
30. Iqbal M., Athar M. Attenuation of iron-nitrilotriacetate (Fe-NTA)-mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylatic treatment of rats with garlic oil. Food Chem. Toxicol. 36:1998;485-495.
31. Saad S.Y., Najjar T.A., Al-Rikabi A.C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res. 43:2001;211-218.
32. Weijl N.I., Hopman G.D., Wipkink-Bakker A., Lentjes E.G., Berger H.M., Cleton F.J.et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann. Oncol. 9:1998;1331-1337.
33. Elsendoorn T.J., Weijl N.I., Mithoe S., Zwinderman A.H., Van Dam F., De Zwarf F.A.et al. Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat. Res. 498:2001;145-158.